Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Endocrinology

Can Congenital Adrenal Hyperplasia Be Inherited? Carrier Risk

At a Glance

If you have congenital adrenal hyperplasia caused by gene variants, you pass one variant to each child. A child usually develops CAH only when the other parent carries a variant in the same gene, so genetic counseling and testing can clarify risks and family-planning options.

If you have congenital adrenal hyperplasia (CAH) caused by a specific gene variant, you will pass one of your variant genes to your biological children. However, whether your child is born with the condition depends mostly on your partner’s genetics [1].

CAH is a group of autosomal recessive conditions, meaning it requires two disease-causing genetic changes (called pathogenic variants)—one inherited from each parent—to be present in the same gene for a person to have the condition [1]. The most common form of CAH is 21-hydroxylase deficiency, caused by variants in the CYP21A2 gene [1]. If your partner does not carry a pathogenic variant in the exact same gene that causes your CAH, your children will be carriers (they will inherit one variant from you) but will usually not have the condition [1].

If your CAH is caused by CYP21A2 and your partner is confirmed to be a carrier of a variant in the same gene, there is a 50% chance with each pregnancy that your child will inherit two variants and have CAH [1]. If your partner also has CAH caused by the same gene, all of your children will inherit two variants [1]. Note that having two pathogenic variants does not always mean a child will have the severe “classic” form of CAH; the specific variants inherited help predict the severity, though they cannot perfectly forecast the exact symptoms [2].

Carrier Risk in the General Population

Many people are carriers of a CAH gene variant and do not know it, as carriers usually do not show symptoms of classic CAH [1]. The likelihood of your partner being a carrier depends on their ancestry and which specific variants are considered [3] [4].

For example, the classic form of 21-hydroxylase deficiency is estimated to occur in roughly 1 in 15,000 to 20,000 births globally [5] [6]. However, the carrier frequency for milder, non-classic variants is much higher in certain populations. One study estimated that 15% of people of Ashkenazi Jewish descent and roughly 9.5% of the US Caucasian study population were carriers of a non-classic variant [4]. In some specific geographic or founder populations (communities originating from a small group of ancestors), the prevalence can be even higher [7]. Because these are only population averages, they do not replace the need for specialized genetic testing for your partner.

Genetic Counseling and Partner Testing

If you have CAH or know you are a carrier and are planning a family, medical guidelines recommend preconception genetic counseling and partner testing [8] [9].

A genetic counselor is a specialized healthcare professional who can help you understand your risks based on your exact genetic variants and family history [10]. Before testing your partner, it is usually necessary to molecularly confirm your own specific genetic variants [11].

Testing for CYP21A2 is technically complex. The gene has a highly similar pseudogene (a piece of DNA that looks like the gene but does not function) located right next to it, which can cause false results in standard tests [12] [13]. Standard carrier screening panels might miss complex structural changes or deletions. It is important that your partner receives testing through a laboratory experienced with CAH that looks closely at the full CYP21A2 gene [9] [12]. It is also important to know that no test is perfect; a negative result significantly reduces the risk that your partner is a carrier, but it cannot completely eliminate the risk of rare or hard-to-detect variants [13].

Family Planning Options and Pregnancy Considerations

If testing reveals that your partner is a carrier, a genetic counselor can walk you through your family planning options. These may include:

  • Natural conception with or without prenatal diagnosis.
  • Prenatal diagnosis, such as chorionic villus sampling (CVS) or amniocentesis, to test the fetus during pregnancy [9] [14]. These are invasive procedures with some risks.
  • In vitro fertilization (IVF) with PGT-M (preimplantation genetic testing for monogenic diseases), which screens embryos for the specific CAH variants present in your family before implantation [9] [12]. This requires knowing the exact familial variants and building a custom test.

Pregnancy with CAH: If you are the one with CAH, you must carefully manage your condition during pregnancy. Do not stop or change your glucocorticoid or mineralocorticoid replacement therapy without consulting your endocrinologist [8]. Pregnancy, severe morning sickness, and labor can cause physical stress that requires coordinated care between your endocrinologist and an obstetrician experienced in high-risk pregnancies to adjust your medication dosages and prevent an adrenal crisis [8].

Common questions in this guide

If I have CAH, will my children automatically have it?
No. CAH is usually autosomal recessive, so a child generally needs disease-causing variants in the same gene from both biological parents. A person with CAH passes one variant to each child, and the child’s risk depends on whether the other parent carries a variant in that same gene.
What is the chance that my partner carries a CAH gene variant?
The chance varies with ancestry and with the specific CAH gene variant being considered; some founder populations have higher carrier frequencies. Population estimates cannot determine an individual’s risk, so specialized genetic testing is needed.
If my CAH involves CYP21A2, what genetic test should my partner have?
Your own CAH variants should usually be confirmed first. Your partner should then have testing that examines the full CYP21A2 gene, including complex changes and deletions, through a laboratory experienced with CAH because a nearby inactive DNA copy can complicate results.
Does a negative CAH carrier test eliminate my partner’s risk?
No. A negative result substantially lowers the chance that your partner carries a detectable variant, but it cannot rule out every rare or hard-to-detect change. A genetic counselor can explain the remaining risk based on the test and your family’s variants.
What family-planning options are available if my partner is a CAH carrier?
Options may include natural conception, with or without prenatal testing, prenatal diagnosis using chorionic villus sampling or amniocentesis, and IVF with PGT-M to test embryos before implantation. Because prenatal tests are invasive and PGT-M requires the exact family variants plus a custom test, a genetic counselor can help you compare choices.
How should CAH be managed during pregnancy?
If you have CAH, do not stop or change glucocorticoid or mineralocorticoid replacement without speaking with your endocrinologist. Pregnancy, severe morning sickness, and labor can require coordinated care with an obstetrician experienced in high-risk pregnancy so medication doses can be adjusted and adrenal crisis prevented.
If both parents have CAH from the same gene, what is the child’s risk?
If both parents have CAH caused by variants in the same gene, all of their children will inherit two variants in that gene. The specific variants influence whether the condition is classic or non-classic and how severe it may be, but they cannot predict every symptom exactly.

Get notified when new evidence is published on Congenital adrenal hyperplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.

    Parsa AA, New MI

    The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):2-11 doi:10.1016/j.jsbmb.2016.06.015.

    PMID: 27380651
  2. 2

    Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

    Choi JH, Kim GH, Yoo HW

    Annals of pediatric endocrinology & metabolism 2016; (21(1)):1-6 doi:10.6065/apem.2016.21.1.1.

    PMID: 27104172
  3. 3

    The Spectrum of Genetic Defects in Congenital Adrenal Hyperplasia in the Population of Cyprus: A Retrospective Analysis.

    Neocleous V, Fanis P, Toumba M, et al.

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2019; (51(9)):586-594 doi:10.1055/a-0957-3297.

    PMID: 31505704
  4. 4

    Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians.

    Hannah-Shmouni F, Morissette R, Sinaii N, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(11)):1276-1279 doi:10.1038/gim.2017.46.

    PMID: 28541281
  5. 5

    Congenital Adrenal Hyperplasia in the Mediterranean: A Concise Overview.

    Fanis P, Skordis N, Tomazou M, et al.

    Pharmaceuticals (Basel, Switzerland) 2026; (19(5)) doi:10.3390/ph19050741.

    PMID: 42198415
  6. 6

    Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol.

    Miller WL

    Hormone research in paediatrics 2019; (91(6)):416-420 doi:10.1159/000501396.

    PMID: 31450227
  7. 7

    The prevalence and genotype of 21-hydroxylase deficiency in the Croatian Romani population.

    Dumic KK, Grubic Z, Kusec V, et al.

    Frontiers in endocrinology 2023; (14()):1170449 doi:10.3389/fendo.2023.1170449.

    PMID: 37324261
  8. 8

    The importance and implications of preconception genetic testing for accurate fetal risk estimation in 21-hydroxylase congenital adrenal hyperplasia (CAH).

    Rama Chandran S, Loh LM

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2019; (35(1)):28-31 doi:10.1080/09513590.2018.1490399.

    PMID: 30044156
  9. 9

    The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum.

    Maher JY, Gomez-Lobo V, Merke DP

    Reviews in endocrine & metabolic disorders 2023; (24(1)):71-83 doi:10.1007/s11154-022-09770-5.

    PMID: 36399318
  10. 10

    Issues with the Detection of Large Genomic Rearrangements in Molecular Diagnosis of 21-Hydroxylase Deficiency.

    Concolino P

    Molecular diagnosis & therapy 2019; (23(5)):563-567 doi:10.1007/s40291-019-00415-z.

    PMID: 31317337
  11. 11

    Genetics of Congenital Adrenal Hyperplasia.

    Hannah-Shmouni F, Chen W, Merke DP

    Endocrinology and metabolism clinics of North America 2017; (46(2)):435-458 doi:10.1016/j.ecl.2017.01.008.

    PMID: 28476231
  12. 12

    EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency.

    Baumgartner-Parzer S, Witsch-Baumgartner M, Hoeppner W

    European journal of human genetics : EJHG 2020; (28(10)):1341-1367 doi:10.1038/s41431-020-0653-5.

    PMID: 32616876
  13. 13

    Nationwide carrier screening for congenital adrenal hyperplasia: integrated approach of CYP21A2 pathogenic variant genotyping and comprehensive large gene deletion analysis.

    Suwanlikit Y, Panthan B, Chitayanan P, et al.

    BMC medical genomics 2025; (18(1)):18 doi:10.1186/s12920-025-02089-5.

    PMID: 39856693
  14. 14

    Prenatal genetic testing and treatment for congenital adrenal hyperplasia.

    Simpson JL, Rechitsky S

    Fertility and sterility 2019; (111(1)):21-23 doi:10.1016/j.fertnstert.2018.11.041.

    PMID: 30611408

This page is for informational purposes only and does not constitute medical advice. Discuss your CAH genetic results, pregnancy plans, and medication changes with a genetic counselor and endocrinologist; pregnancy care may also involve an obstetrician experienced in high-risk pregnancies.